SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : GUMM - Eliminate the Common Cold
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Mike M who wrote (53)1/29/1999 3:20:00 AM
From: Dan B.  Read Replies (1) of 5582
 
I don't doubt that. But what Gary Kehoe knows and what you know about Gary is not going to convince Wall Street to jump on this stock- and if Gary were to hype this swiftly and vehemently as a cure for the common cold I'm sure the street would trash GUMM with equal ferver 'til it learned better of the matter. I only discovered this stock/thread yesterday, and I saw an obvious explanation for the lack of upside pricing on the news. As I say, assuming the product/method works well, the product should do well in time by word of mouth alone. That Gary Kehoe would downplay this is wise. Given the talk here of Cleveland Clinic test results not having been "quite" replicated(and even if they were), I'd say this product should not be called a true cure for the common cold, but rather simply a greatly beneficial product. Actually, being from Ohio originally, I have great respect for the reputation of the Cleveland Clinic in general, it's definitely a good name to bandy about if one wanted to hype!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News